Stock screenerAll disclosures →
EDGAR →
GH
Conviction 100HealthcareScan · Mon, Jul 20, 2026Bearish engulfing
GH$148.09-4.99%
ResistanceSupportVol 14Insider buyInsider sellCongress buyCongress sell4
2
2
8
3
Vol MA14 3.62M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price148.09
Change-4.99%
Gap+0.43%
Rel volume3.86×
Avg volume4.1M
Avg $ vol628.28M
SMA 20154.19
SMA 50132.56
SMA 200103.42
Price vs 50+11.72%
Price vs 200+43.19%
MA stackbullish
50/200 cross—
Supertrendup · 145.43
RSI (14)50
MACD hist-2.42
MACD crossbear · 5d
Stoch %K / %D2 / 22
ADX (14)43
+DI / −DI27 / 19
RSI divergence—
MACD divergence—
ATR %+5.34%
ADR %5.11%
52w high170.77
52w low40.98
From 52w high-13.28%
Above 52w low+261.37%
New 52w highNo
SqueezeOff
Bollinger width30.23%
%B0.37
Donchian pos46.92%
Donchian high174.08
Donchian low125.12
AVWAP (52w high)157.12
vs AVWAP high-5.75%
AVWAP (52w low)97.75
vs AVWAP low+51.49%
OBV trendUp
Chaikin MF (20)-0.08
Today vs 20d3.86×
Avg vol (14d)3.62M
Avg vol (20d)4.1M
Avg $ vol (20d)628.28M
Market cap19.64B
RS 3m (vs SPY)+75.95%
RS 6m (vs SPY)+35.86%
RS line new highNo
Trend template8/8
Technical rank85.5
1 week-6.51%
1 month+14.70%
3 months+63.89%
6 months+32.25%
1 year+213.22%
YTD+45.56%
P/E-47.17
P/B-108.45
P/S20.00
P/FCF-84.25
EPS-3.32
Div yield—
ROE229.89%
ROA-21.73%
Debt/Eq-8.30
Current4.68
EV/EBITDA-50.69
Gross margin—
Net margin-42.39%
Rev growth32.88%
EPS growth4.61%
Price target171.79
Target upside16.00%
Analyst ratingBuy
Institutional115.72%
Ent. value20.15B
Revenue301.67M
Net income-112.08M
Gross profit—
Free cash flow-233.07M
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNasdaq
Shares out132.6M
Employees2.51K
ListedThu, Oct 4, 2018
Free float126.19M
Float %96.2%
Short interest12.14M
Days to cover2.9d
Short volume27.9%
Squeeze score49 / 100
Next earningsThu, Jul 30, 2026 · after (10d)
EPS forecast−$0.74 · 3 est
Last EPS vs est−$0.85 vs −$0.71
Last surprise-19.7% miss
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank85.5 / 100
Group rank23 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish engulfing
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GH · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Sheldon Whitehouse senate · D · RI · traded 2025-11-21 | Buy | $1K–$15K | 2025-11-21 | 2025-12-01 |
Insider activity
SEC Form 4 transactions in GH · 2 buys · 8 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Tariq Musa Director · Common Stock · 2026-07-16 | Sell | 116 | $19K | 2026-07-16 | 2026-07-16 |
Tariq Musa Director · Restricted Stock Units · 2026-07-15 | Exercise | 250 | — | 2026-07-15 | 2026-07-16 |
Tariq Musa Director · Common Stock · 2026-07-15 | Exercise | 250 | — | 2026-07-15 | 2026-07-16 |
Talasaz AmirAli Co-Chief Executive Officer · Common Stock · 2026-06-29 | Sell | 70.51K | $11M | 2026-06-29 | 2026-06-30 |
Talasaz AmirAli Co-Chief Executive Officer · Common Stock · 2026-06-29 | Sell | 40 | $6K | 2026-06-29 | 2026-06-30 |
Talasaz AmirAli Co-Chief Executive Officer · Stock Option (Right to Buy) · 2026-06-29 | Exercise | 143.03K | — | 2026-06-29 | 2026-06-30 |
Talasaz AmirAli Co-Chief Executive Officer · Common Stock · 2026-06-29 | Sell | 46.66K | $7.1M | 2026-06-29 | 2026-06-30 |
Talasaz AmirAli Co-Chief Executive Officer · Common Stock · 2026-06-29 | Exercise | 143.03K | $598K | 2026-06-29 | 2026-06-30 |
Talasaz AmirAli Co-Chief Executive Officer · Common Stock · 2026-06-29 | Sell | 25.81K | $3.9M | 2026-06-29 | 2026-06-30 |
Talasaz AmirAli Co-Chief Executive Officer · Common Stock · 2026-06-26 | Sell | 64.04K | $9.6M | 2026-06-26 | 2026-06-30 |
SEC filings
EDGAR filings in GH · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.